newsfilter
← Latest News
PR Newswire·

Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash

Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immuno-oncology and...